HU01 Curriculum Vitae - European Society for Biomaterials

HU01 Curriculum Vitae - European Society for Biomaterials

NAME / SURNAME : VILAMITJANA – AMEDEE Joëlle - Birth : 8 Novembre 1959
APPOINTMENTS
· Research Associate Professor Inserm (2ème level : 1988 ; 1st level 1992)
· Research Professor Inserm (2ème level , 1999; 1st level 2012)
· Head of the team « Cell and Tissue engineering » of Inserm U577 (2003 – 2007)
· Head of Inserm U577, University Victor Segalen Bordeaux 2 (2007-2011)
· Head of Inserm U1026, University Bordeaux Segalen (2011-2016).
EDUCATION
· PhD in Cell and Molecular Biology – University of Bordeaux 2, 1985
· Habilitation à Diriger des Recherches (Authorization for PhD training) University of Bordeaux 2, 1993
PROFESSIONAL EXPERIENCE
· Role of RNA Polymerase II subunits on transcription assays (1982-1985)
· Analysis of transcription assays of specific genes INSERM U184, Strasbourg P. Chambon (July 1984)
· The use of monoclonal antibodies for detection of human osteoarthitic cartilage - Cis-BIO CEA Marcoule (France) (19861988).
· Quantification of intracellular calcium using fluorescent probes » Application to cell signaling and cell adhesion » Babraham
Institute, Cambridge, UK. F. Mac Donald, P. Lipp. (July - August 2000).
· Fonctionalization of biomaterials using bioactive molecules. Université de Zhejiang Department of Polymer and Sciences –
Hangzou, Chine. Pr. Ji Jian, (March 2004).
. Calcium phosphate - based biomaterials and role of Ca Sensing Receptor (CaSR) in bone tissue engineering. Institute for
Bioengineering of Catalona (IBEC) (Spain). Pr. J. Planell. Mai--July 2010.
EXPERTISE
Bone tissue engineering - Adult stem cells differentiation from human bone marrow - Osteogenesis and angiogenesis couplingcell / biomaterial interfaces. Cell to cell communication
TEACHING ACTIVITIES AND TRAINING
Teaching in severai Masters in Cell Biology; Bone Physiopathology ; Masters in Biomaterials, (University Bordeaux 2,
University Paris 7, Paris 5) – Training : Masters, PHD students (12 PhD from 1993)
SCIENTIFIC ACTIVITIES
· Member of « Commission Scientifique Spécialisée » CSS7 of Inserm (2003-2007)
. Member of « Commission Scientifique Spécialisée » CSS8 of Inserm (2012-2016)
· Member of « Commission de Spécialistes 65ème section » "Cell Biology" from 2000.
Member of « Conseil Scientifique de l’Université Bordeaux 2 Victor Segalen from 2008.
Member of « Conseil Scientifique de l’Institut Français de la Recherche en Odontologie (IFRO) from 2004.
· Member of « Comité d’Interface INSERM / Odontologie from 2004.
· Expertise activities: for ANR (Blanc, Jeunes chercheurs, TECSAN, PCV, BIOTECS, Emergence Bio) for DSPT5 from 2004
and for AERES, International expertises (Canada, NIH)
· Reviewer activities «Biomaterials, J. Biomed Mat Res, J Bone Min Res., Bone, J. Tiss Eng Reg Med, Acta Biomaterialia, J
Biomech. Tissue Eng, Eur Cell Mater, Bone, Calcified Tissue, J. Mechanics , Acta Biomaterialia .
. Co-author of 102 peer-reviewed publications, 5 chapters reviews, 3 international patents and around 200 communications and
conferences
SCIENTIFIC SOCIETIES
· American Society for Bone and Mineral Research (ASBMR), from 1993
· European Society for Biomaterials, from 1996. Member to ESB committee from 2011.
· French Society of Mineral Tissue Biology from 1998 and President of the French Society of Mineral Tissue Biology (1999 -2003).
FUNDS AND CONTRACTS
Funds from: GBM Aquitaine, Conseil Régional d'Aquitaine, Agence de Biomédecine, Inserm ProA, RNTS, Fondation de
l'Avenir, ANR PNANO, ANR Blanc, ANR TECSAN. ANR Emergence, FRSQ Inserm. « Fondation pour la Recherche Médicale »
At the European level, partner to several European Actions BIOMED 2(1985-1988) - Skeletal Implant, (1993-1996) - BITES
(1999-2002.) - COST NAMABIO FP7 (2011-2013), EuroNanoMed FP7 NANGIOFRAC (2012-2015). “Programme de
Recherche Avancée (PRA) with China, Greece, with Marroco (2011-2013), Portugal (2012-2014).
MAIN REPRESENTATIVE PUBLICATIONS from 2009
1. Velard F, Schlaubitz S, Fricain JC, Guillaume D, Laurent-Maquin D, Möller-Siegert J, Vidal L, Jallot E, Sayen S, Raissle O,
Nedelec JM, Vix-Guterl C, Anselme K, Amédée J*, Laquerrière P*. In vitro and in vivo evaluation of the inflammatory
potential of various nanoporous hydroxyapatite biomaterials. Nanomedicine in press.
2. The Use of Total Human Bone Marrow Fraction in a Direct Three-Dimensional Expansion Approach for Bone Tissue
Engineering Applications: Focus on Angiogenesis and Osteogenesis. Guerrero J, Oliveira H, Catros S, Siadous R, Derkaoui
SM, Bareille R, Letourneur D, Amédée J. Tissue Eng Part A. 2014 Oct 21.
3. Velard F, Braux J, Amédée J*, Laquerriere P*. Inflammatory cell response to calcium phosphate biomaterial particles: An
overview. Acta Biomater 2013;9:4956-4963.
4. A polysaccharide based macroporous matrix for bone tissue engineering. Jean Christophe Fricain, Silke Schlaubitz,
Catherine Le Visage, Isabelle Arnault, Sidi Mohammed Derkaoui, Robin Siadous, Sylvain Catros, Charlotte Lalande, Reine
Bareille, Martine Renard, Thierry Fabre, Sandro Cornet, Marlène Durand, Alain Léonard, Nouredine Sahraoui, Didier
Letourneur, Joëlle Amédée. Biomaterials, 2013,34(12):2947-59
5. Fricain JC, Schlaubitz S, Le Visage C, Arnault I, Derkaoui SM, Siadous R, Catros S, Lalande C, Bareille R, Renard M,
Fabre T, Cornet S, Durand M, Léonard A, Sahraoui N, Letourneur D, Amédée J. A nano-hydroxyapatite - Pullulan/dextran
Page 1 sur 2
polysaccharide composite macroporous material for bone tissue engineering. Biomaterials 2013;34:2947-2959.
6. Li H, Daculsi R, Bareille R, Bourget C, Amédée J. uPA and MMP-2 were involved in self-assembled network formation in a
two dimensional co-culture model of bone marrow stromal cells and endothelial cells. Journal of Cellular Biochemistry
2013;114:650-657.
7. Catros S, Guillemot F, Nandakumar A, Ziane S, Moroni L, Habibovic P, van Blitterswijk C, Rousseau B, Chassande O,
Amédée J, Fricain JC. Layer-by-Layer Tissue Microfabrication Supports Cell Proliferation In Vitro and In Vivo. Tissue
Engineering Part C 2012;18:62-70.
8. Thebaud N, Siadous R, Bareille R, Remy M, Daculsi R, Amédée J, Bordenave L. Whatever their differentiation status,
human progenitor derived - or mature - endothelial cells induce osteoblastic differentiation of bone marrow stromal cells.
Journal of Tissue Engineering and Regenerative Medicine 2012;6:e51-e60.
9. Catros S, Fricain J-C, Guillotin B, Pippenger B, Bareille R, Remy M, Lebraud E, Desbat B, Amédée J, Guillemot F. Laserassisted bioprinting for creating on-demand patterns of human osteoprogenitor cells and nano-hydroxyapatite. Biofabrication
2011;3(2):025001.
10. Bidarra SJ, Barrias CC, Barbosa MA, Soares R, Amédée J, Granja PL. Phenotypic and proliferative modulation of human
mesenchymal stem cells via crosstalk with endothelial cells. Stem Cell Research 2011;7:186-197.
11. Lalande C, Miraux S, Derkaoui SM, Mornet S, Bareille R, Fricain JC, Franconi JM, Le Visage C, Letourneur D, Amédée J,
Bouzier –Sore AK. Magnetic Resonance Imaging Tracking Of Human Adipose Derived Stromal Cells Within ThreeDimensional Scaffolds For Bone Tissue Engineering. European Cells & Materials 2011;21:341-354.
12. Guillemot F, Guillotin B, Fontaine A, Ali M, Catros S, Keriquel V, Fricain JC, Remy M, Bareille R, Amédée-Vilamitjana J.
Laser-assisted bioprinting to deal with tissue complexity in regenerative medicine. MRS Bulletin 2011;36:1015-1019.
13. Li H, Daculsi R, Grellier M, Bareille R, Bourget C, Remy M, Amédée J. The Role of Vascular Actors in Two Dimensional
Dialogue of Human Bone Marrow Stromal Cell and Endothelial Cell for Inducing Self-Assembled Network. Plos One 2011;6.
14. Li H, Daculsi R, Grellier M, Bareille R, Bourget C, Amédée J. Role of neural-cadherin in early osteoblastic differentiation of
human bone marrow stromal cells cocultured with human umbilical vein endothelial cells. American Journal of PhysiologyCell Physiology 2010;299:C422-C430.
15. Guillotin B, Souquet A, Catros S, Duocastella M, Pippenger B, Bellance S, Bareille R, Remy M, Bordenave L, Amédée J,
Guillemot F. Laser assisted bioprinting of engineered tissue with high cell density and microscale organization. Biomaterials
2010;31:7250-7256.
16. Keriquel V, Guillemot F, Arnault I, Guillotin B, Miraux S, Amédée J, Fricain JC, Catros S. In vivo bioprinting for computerand robotic-assisted medical intervention: preliminary study in mice. Biofabrication 2010; 2.
17. Guillemot F, Souquet A, Catros S, Guillotin B, Lopez J, Faucon M, Pippenger B, Bareille R, Remy M, Bellance S,
Chabassier P, Fricain JC, Amédée J. High-throughput laser printing of cells and biomaterials for tissue engineering. Acta
Biomater 2010;6:2494-2500
18. Grellier M, Bareille R, Bourget C, Amédée J. Responsiveness of human bone marrow stromal cells to shear stress. Journal
of Tissue Engineering and Regenerative Medicine 2009;3:302-309.
19. Grellier M, Ferreira-Tojais N, Bourget C, Bareille R, Guillemot F, Amédée J. Role of Vascular Endothelial Growth Factor in
the Communication Between Human Osteoprogenitors and Endothelial Cells. Journal of Cellular Biochemistry
2009;106:390-398.
20. Grellier M, Bordenave L, Amédée J. Cell-to-cell communication between osteogenic and endothelial lineages: implications
for tissue engineering. Trends in Biotechnology 2009;27:562-571.
21. Grellier M, Granja PL, Fricain JC, Bidarra SJ, Renard M, Bareille R, Bourget C, Amédée J. Barbosa MA. The effect of the
co-immobilization of human osteoprogenitors and endothelial cells within alginate microspheres on mineralization in a bone
defect. Biomaterials 2009;30:3271-3278.
22. Catros S, Zwetyenga N, Bareille R, Brouillaud B, Renard M, Amédée J, Fricain JC. Subcutaneous-Induced Membranes
Have No Osteoinductive Effect on Macroporous HA-TCP In Vivo. Journal of Orthopaedic Research 2009;27:155-161.
23. Malaval L, Monfoulet L, Fabre T, Pothuaud L, Bareille R, Miraux S, Thiaudiere E, Raffard G, Franconi JM, Lafage-Proust
MH, Aubin JE, Vico L, Amédée J. Absence of bone sialoprotein (BSP) impairs cortical defect repair in mouse long bone.
Bone 2009;45:853-861.
24. Pallu S, Fricain JC, Bareille R, Bourget C, Dard M, Sewing A, Amédée J. Cyclo-DfKRG peptide modulates in vitro and in
vivo behavior of human osteoprogenitor cells on titanium alloys. Acta Biomater 2009;5:3581-3592.
25. Rerat V, Dive G, Cordi AA, Tucker GC, Bareille R, Amédée J, Bordenave L, Marchand-Brynaert J. alpha(v)beta(3) IntegrinTargeting Arg-Gly-Asp (RGD) Peptidomimetics Containing Oligoethylene Glycol (OEG) Spacers. Journal of Medicinal
Chemistry 2009;52:7029-7043.
Joëlle AMEDEE VILAMITJANA
Research Professor Inserm
Page 2 sur 2